2598762
doi
10.5281/zenodo.2598762
oai:zenodo.org:2598762
user-labscribbles
user-sgc-opennotebook
user-openlabnotebooks
Arrowsmith, Cheryl
Structural Genomics Consortium, University of Toronto
Lee, Matt
CHDI Foundation
A time-course analysis using Differential Static Light Scattering (DSLS) of purified HTT1-3144 Q23 - 2019/01/28
Harding, Rachel
Structural Genomics Consortium, University of Toronto
info:eu-repo/semantics/openAccess
Creative Commons Attribution 4.0 International
https://creativecommons.org/licenses/by/4.0/legalcode
DSLS
Differential Static Light Scattering
Huntingtin
HTT
Huntington's disease
<p><strong>Project: </strong>Biophysical investigation of purified HTT protein samples</p>
<p><strong>Experiment: </strong>A time-course analysis using Differential Static Light Scattering (DSLS) of purified HTT<sup>1-3144</sup>Q23 </p>
<p><strong>Date completed:­ </strong>2019/01/28</p>
<p><strong>Rationale: </strong>Time and resources in the HD field have been primarily focussed on understanding HTT aggregation looking as caspase cleavage products spanning aa. 1-586 or exon 1 spanning aa. 1-90. However, we know that HTT protein purified in its apo form is able to self-associate into larger oligomeric species and that monomer, dimer and larger species are found following FLAG-affinity chromatography as determined by size-exclusion chromatography (SEC) and SEC-multi-angle light scattering (SEC-MALS). This experiment aimed to begin to investigate how HTT self-associates and aggregates over time in a range of different conditions. </p>
Dr. Harding is the recipient of the Huntington's Disease Society of America Berman Topper Career Development Fellowship which funds and supports this research, in addition to generous funding from the CHDI Foundation and the Huntington Society of Canada. The SGC is a registered charity (number 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada through Ontario Genomics Institute [OGI-055], Innovative Medicines Initiative (EU/EFPIA) [ULTRA-DD grant no. 115766], Janssen, Merck KGaA, Darmstadt, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Research, Innovation and Science (MRIS), Pfizer, São Paulo Research Foundation-FAPESP, Takeda, and Wellcome.
Zenodo
2019-01-28
info:eu-repo/semantics/other
2598761
user-labscribbles
user-sgc-opennotebook
user-openlabnotebooks
1579591413.796162
71510
md5:1291b37c552214fd04f08acf5f696885
https://zenodo.org/records/2598762/files/DSLS_20190128.xlsx
382067
md5:bfb32f0e621044c3526900b6802013cb
https://zenodo.org/records/2598762/files/A time-course analysis using Differential Static Light Scattering (DSLS) of purified HTT1-3144 Q23 20190128.docx
public
10.5281/zenodo.2598761
isVersionOf
doi